Factors that contribute to inhibition of methacholine-induced bronchoconstriction

• Published in: The American review of respiratory disease Vol. 133; no. 5; p. 735
• Main Authors: Greenspon, L W, Morrissey, W L
• Format: Journal Article
• Language: English
• Published: United States 01.05.1986
• Subjects: Adult; Asthma - drug therapy; Asthma - physiopathology; Bronchi - drug effects; Bronchi - physiopathology; Bronchial Spasm - chemically induced; Female; Humans; Isoproterenol - therapeutic use; Male; Methacholine Chloride; Methacholine Compounds - pharmacology
• ISSN: 0003-0805

To evaluate the factors that contribute to inhibition of airways reactivity, we compared the effect of inhaled isoproterenol, 125 micrograms, on the response to methacholine-induced bronchoconstriction in 10 normal and 10 asthmatic subjects. We measured in each subject baseline lung function, response to inhaled bronchodilator, dose of bronchodilator causing 50% maximal response, and degree of airways reactivity to inhalation of methacholine before and after isoproterenol. In asthmatics, but not normal subjects, inhalation of isoproterenol led to significant inhibition of methacholine-induced bronchospasm. In asthmatics, the greater the airways reactivity to methacholine the greater the inhibition by isoproterenol (p less than 0.05). In both groups, there was significant correlation between baseline lung function and level of airways reactivity. In neither normal subjects nor asthmatics did the maximal bronchodilator response to isoproterenol inhalation correlate with inhibition of airways reactivity. Studies evaluating inhibition of airways reactivity should take into account the population tested, baseline lung function, and baseline level of airways reactivity.